Company Update (NYSE:COV): Covidien’s Fortrex™ PTA Balloon Receives FDA 510(k) Clearance

[Business Wire] – Covidien plc today announced U.S. Food and Drug Administration 510 clearance for its Fortrex™ over-the-wire percutaneous transluminal angioplasty balloon catheter. Read more on this. Covidien plc (COV), with a . . . → Read More: Company Update (NYSE:COV): Covidien’s Fortrex™ PTA Balloon Receives FDA 510(k) Clearance Similar Articles: Stock Update (NYSE:COV): Covidien’s HawkOne™ Directional Atherectomy System Receives FDA 510(K) Clearance for the Treatment of Peripheral Arterial Disease Company Update (NYSE:COV): Covidien Acquires Reverse Medical Corporation Company Update: Covidien plc (NYSE:COV) – Covidien Opens Advanced Medical Technology Center in Brazil